Cite
HARVARD Citation
Prentice, R. et al. (2020). Asymptomatic screening for SARS CoV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice.. Digestive and liver disease. 52 (11), pp. 1250-1251. [Online].